Formycon AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
276.20
12,585.00
16,925.00
19,533.00
29,003.50
42,993.50
Cost of Goods Sold (COGS) incl. D&A
5,502.00
9,874.90
13,676.80
21,203.80
27,859.70
33,101.70
Gross Income
5,225.80
2,710.10
3,248.20
1,670.80
1,143.90
9,891.80
SG&A Expense
2,549.90
1,926.90
-
-
-
2,886.10
EBIT
7,783.80
781.60
3,246.70
1,673.70
1,143.90
7,119.30
Unusual Expense
-
-
5.00
-
-
0.10
Non Operating Income/Expense
11.10
78.50
2,735.70
2,425.70
2,681.50
6.70
Interest Expense
2.00
-
-
-
42.10
33
Pretax Income
7,767.40
860.30
577.50
4,066.10
1,578.40
7,098.50
Income Tax
-
-
-
-
3.00
0.20
Consolidated Net Income
7,767.40
860.30
577.50
4,066.10
1,581.40
7,098.60
Net Income
7,767.40
860.30
577.50
4,066.10
1,581.40
7,098.60
Net Income After Extraordinaries
7,767.40
860.30
577.50
4,066.10
1,581.40
7,098.60
Net Income Available to Common
7,767.40
860.30
577.50
4,066.10
1,581.40
7,098.60
EPS (Basic)
0.90
0.10
0.06
0.45
0.17
0.75
Basic Shares Outstanding
8,626.70
8,626.70
9,079.60
9,099.60
9,343.90
9,422.60
EPS (Diluted)
0.90
0.10
0.06
0.45
0.17
0.75
Diluted Shares Outstanding
8,626.70
8,626.70
9,079.60
9,099.60
9,343.90
9,422.60
EBITDA
6,680.70
1,853.60
4,181.50
974.80
1,928.60
8,023.60
Other Operating Expense
8.10
1.60
1.40
2.90
-
113.60
Non-Operating Interest Income
7.40
0.20
71.50
33.20
1.40
5.50

About Formycon

View Profile
Address
Fraunhoferstraße 15
Munich Bayern (Bavaria) 82152
Germany
Employees -
Website http://formycon.com
Updated 07/08/2019
Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205 which focusoin the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany.